Development of a qualitative liquid chromatography/tandem mass spectrometric method for the detection of narcotics in urine relevant to doping analysis
- 20 August 2007
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 21 (18) , 3015-3023
Abstract
A new screening procedure for 18 narcotics in urine for anti‐doping purposes has been developed using liquid chromatography/triple quadrupole mass spectrometry (LC/MS). Electrospray ionization (ESI) was used as interface. Infusion experiments were performed for all substances to investigate their mass spectrometric behaviour in terms of selecting product specific ions. These product ions were then used to develop a tandem mass spectrometric method using selected reaction monitoring (SRM). For the LC/MS analysis, chromatography was performed on an octadecylsilane column. The total run time of the chromatographic method was 5.5 min. For the sample preparation prior to LC/MS analysis, the urine samples were liquid‐liquid extracted at pH 9.5 after overnight enzymatic hydrolysis. Two extraction solvents were evaluated: dichloromethane/methanol 9/1 (v/v), which is currently used for the extraction of narcotics, and diethyl ether, used for the extraction of steroids. With diethyl ether the detection limits for all compounds ranged between 0.5 and 20 ng/mL and with the mixture containing dichloromethane the detection limits ranged between 0.5 and 10 ng/mL. Taking into account the minimum required performance limits of the World Anti‐Doping Agency of 200 ng/mL for narcotics, diethyl ether can also be considered as extraction solvent for narcotics. Finally, the described method was applied to the analysis of urine samples previously found to contain narcotics by our routine gas chromatography/mass spectrometry (GC/MS) method. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 23 references indexed in Scilit:
- Doping control analysis in human urine by liquid chromatography–electrospray ionization ion trap mass spectrometry for the Olympic Games Athens 2004: Determination of corticosteroids and quantification of ephedrines, salbutamol and morphineAnalytica Chimica Acta, 2006
- Screening for amphetamine and amphetamine‐type drugs in doping analysis by liquid chromatography/mass spectrometryRapid Communications in Mass Spectrometry, 2006
- LC–ESI‐MS/MS analysis for the quantification of morphine, codeine, morphine‐3‐β‐D‐glucuronide, morphine‐6‐β‐D‐glucuronide, and codeine‐6‐β‐D‐glucuronide in human urineJournal of Mass Spectrometry, 2005
- Identification of Fentanyl, Alfentanil, Sufentanil, Remifentanil and Their Major Metabolites in Human Urine by Liquid Chromatography/Tandem Mass Spectrometry for Doping Control PurposesEuropean Journal of Mass Spectrometry, 2005
- Development of a multi‐target screening analysis for 301 drugs using a QTrap liquid chromatography/tandem mass spectrometry system and automated library searchingRapid Communications in Mass Spectrometry, 2005
- Detection of androst‐4‐ene‐3,6,17‐trione (6‐OXO®) and its metabolites in urine by gas chromatography–mass spectrometry in relation to doping analysisBiomedical Chromatography, 2005
- Determination of fentanyl in human plasma and fentanyl and norfentanyl in human urine using LC–MS/MSJournal of Pharmaceutical and Biomedical Analysis, 2005
- Validation of a screening method for corticosteroids in doping analysis by liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2003
- Urine drug testing for opioids, cocaine, and metabolites by direct injection liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2003
- Metabolism of anabolic steroids in man: synthesis and use of reference substances for identification of anabolic steroid metabolitesAnalytica Chimica Acta, 1993